![Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion | Nature Communications Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-17703-6/MediaObjects/41467_2020_17703_Fig2_HTML.png)
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion | Nature Communications
![HIV and adolescents: focus on young key populations - Bekker - 2015 - Journal of the International AIDS Society - Wiley Online Library HIV and adolescents: focus on young key populations - Bekker - 2015 - Journal of the International AIDS Society - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3b08c1b6-c1ed-4b61-8b71-30c5849461a3/jia20076-fig-0001-m.jpg)
HIV and adolescents: focus on young key populations - Bekker - 2015 - Journal of the International AIDS Society - Wiley Online Library
![Attendance in: Summary Proceedings of the Thirty-Third Annual Meetings of the Board of Governors, 1978 Attendance in: Summary Proceedings of the Thirty-Third Annual Meetings of the Board of Governors, 1978](https://www.elibrary.imf.org/cover/books/015/24089-9781475581300-en/cover-en.jpg)
Attendance in: Summary Proceedings of the Thirty-Third Annual Meetings of the Board of Governors, 1978
![Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion | Nature Communications Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-17703-6/MediaObjects/41467_2020_17703_Fig1_HTML.png)